Laboratornaya sluzhba, Vol. 9, Issue. 4, p. 26. The diagnosis and monitoring of hematological malignancies is complex and requires a systematic approach. Morphology, cell phenotyping, cytogenetics and ...

For example, scientists actually know of 46 blood group systems that have various characteristics and antigens. Now, after ...

In recent decades, the incidence of some hematological malignancies (HMs), such as acute lymphocytic leukemia (ALL) and chronic myeloid leukemia (CML), has decreased, while the incidence of others ...

The Hematological Genetics lab is led by Drs Outi Kilpivaara (geneticist) and Ulla Wartiovaara-Kautto (clinical hematologist). Our research stems from the intriguing curiosity towards mechanisms of ...

Tafasitamab is under clinical development by Incyte and currently in Phase II for Hematological Tumor. According to GlobalData, Phase II drugs for Hematological Tumor does not have sufficient ...

Groundbreaking research has established a new blood group system, the MAL, now recognized as the 47th type. The discovery of ...

We now know why some blood is missing a key antigen—leading to the creation of a new blood-grouping system. Experts believe ...

Asunercept is under clinical development by Apogenix and currently in Phase I for Hematological Tumor. According to GlobalData, Phase I drugs for Hematological Tumor does not have sufficient ...

A new study demonstrates that the combination of lenalidomide (Revlimid) and obinutuzumab (Gazyva) is effective and ...

Vallina, from the CRIS Immuno-Oncology Unit, in Madrid (Spain), explains that a new approach provides 'trained troops' of ...

Silence Therapeutics (SLNCF) targets cardiovascular and hematological diseases with RNA interference therapies. See why I ...

Oncolytics Biotech (ONCY – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...